Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
D000917:Antibody Formation; D004899:Erythroblastosis, Fetal / Q000453:epidemiology / Q000517:prevention & control*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage / Q000627:therapeutic use*; D007231:Infant, Newborn; D007518:Isoantibodies; D008297:Male; D009519:New York City; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D013997:Time Factors
D007136:Immunoglobulins; D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System